BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38646986)

  • 21. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
    Choden S; Wangmo C; Maharjan S
    Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignancy rates for Bethesda III subcategories in thyroid fine needle aspiration biopsy (FNAB).
    Mosca L; Silva LFFD; Carneiro PC; Chacon DA; Araujo-Neto VJF; Araujo-Filho VJF; Cernea CR
    Clinics (Sao Paulo); 2018; 73():e370. PubMed ID: 29846414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP.
    Nishigami K; Liu Z; Taniguchi E; Koike E; Ozaki T; Mori I; Kakudo K
    Endocr J; 2012; 59(6):483-7. PubMed ID: 22484994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
    Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
    Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
    Hong HS; Lee JY
    AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
    Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
    Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study.
    Marina M; Zatelli MC; Goldoni M; Del Rio P; Corcione L; Martorana D; Percesepe A; Bonatti F; Mozzoni P; Crociara A; Ceresini G
    J Endocrinol Invest; 2021 Dec; 44(12):2635-2643. PubMed ID: 33860907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
    Zhou H; Baloch ZW; Nayar R; Bizzarro T; Fadda G; Adhikari-Guragain D; Hatem J; Larocca LM; Samolczyk J; Slade J; Rossi ED
    Cancer Cytopathol; 2018 Jan; 126(1):20-26. PubMed ID: 28941185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis for diagnosis of preoperative non-invasive follicular thyroid neoplasm with papillary-like nuclear features.
    Lee HS; Lee JW; Park JH; Kim WS; Han HS; Lee SE
    PLoS One; 2019; 14(7):e0218046. PubMed ID: 31276506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic criteria of well differentiated thyroid tumor of uncertain malignant potential; a histomorphological and immunohistochemical appraisal.
    Yassin Fel-Z
    J Egypt Natl Canc Inst; 2015 Jun; 27(2):59-67. PubMed ID: 25800580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
    Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
    Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
    Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
    Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal.
    Liu Z; Zhou G; Nakamura M; Koike E; Li Y; Ozaki T; Mori I; Taniguchi E; Kakudo K
    Cancer Sci; 2011 Jan; 102(1):288-94. PubMed ID: 21070478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
    Kim J; Shin JH; Oh YL; Hahn SY; Park KW
    Endocr J; 2022 Jan; 69(1):67-74. PubMed ID: 34408101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
    Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
    BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between ultrasound-based TIRADS and BETHESDA categories in patients undergoing thyroid biopsy.
    Aksoy SH; Uygun O; Yurdaisik I; Ates L; Aydin S
    Clin Exp Med; 2022 Nov; 22(4):661-666. PubMed ID: 35022917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of follicular tumor of uncertain malignant potential of the thyroid: real-world data.
    Ito Y; Hirokawa M; Hayashi T; Kihara M; Onoda N; Miya A; Miyauchi A
    Endocr J; 2022 Jul; 69(7):757-761. PubMed ID: 35082189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical and morphometrical evaluation of well-differentiated thyroid tumor of uncertain malignant potential.
    Mohamed DA; Shamlola MM
    Indian J Pathol Microbiol; 2019; 62(1):17-23. PubMed ID: 30706854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?
    Figge JJ; Gooding WE; Steward DL; Yip L; Sippel RS; Yang SP; Scheri RP; Sipos JA; Mandel SJ; Mayson SE; Burman KD; Folek JM; Haugen BR; Sosa JA; Parameswaran R; Tan WB; Nikiforov YE; Carty SE
    Thyroid; 2021 Nov; 31(11):1673-1682. PubMed ID: 34340592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.